The CancerX initiative, part of the White House-led Cancer Moonshot program, is making significant strides in advancing cancer care through digital innovation. Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe), which co-hosts CancerX, discussed the current state and future directions of the initiative in an interview with MobiHealthNews. Key points include:
Progress and Plans: In its second year, CancerX, under the co-hosting of DiMe and Moffitt Cancer Center, has announced its inaugural members and is preparing to release resources focused on using digital technologies to address financial toxicity and equity in cancer care and research.
Data Sprint and Payment Pilot: A data sprint, in partnership with the Office of the National Coordinator for Health Information Technology (ONC) and the Center for Medicare and Medicaid Innovation (CMMI), is underway. This involves a payment pilot using a FHIR API for claims data, aiming to create datasets for future cancer research.
Inaugural Accelerator and White House Involvement: CancerX is set to announce focus areas for its inaugural accelerator, fostering advancements in five topic areas. The initiative has also engaged with the White House and other federal government entities to support all 17 Moonshot initiatives.
Focus on Reducing Cancer Care Inequities: The President’s cancer panel, focusing on reducing cancer care inequities and leveraging technology for patient navigation, aligns with CancerX’s efforts. Data indicates potential for digital solutions to address equity issues in cancer care.
Future Digital Solutions: CancerX envisions new care models combining clinical decision support, virtual-first care approaches, and digitally enabled navigation to reimagine post-cancer diagnosis care. This approach aims for better, more equitable outcomes at a more affordable cost.